Marc Tessier-Lavigne - Dec 31, 2021 Form 5 Insider Report for Denali Therapeutics Inc. (DNLI)

Role
Director
Signature
/s/ Tyler Nielsen, by power of attorney
Stock symbol
DNLI
Transactions as of
Dec 31, 2021
Transactions value $
$0
Form type
5
Date filed
2/17/2022, 07:25 PM
Previous filing
Dec 30, 2021
Next filing
Jan 5, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DNLI Common Stock Gift $0 -200K -8.91% $0.00 2.04M Dec 13, 2021 Direct F1, F2
holding DNLI Common Stock 78.8K Dec 31, 2021 The Tessier-Lavigne/Hynes Irrevocable Trust 1 F3
holding DNLI Common Stock 79.2K Dec 31, 2021 The Tessier-Lavigne/Hynes Irrevocable Trust 2 F4
holding DNLI Common Stock 78.8K Dec 31, 2021 The Tessier-Lavigne/Hynes Irrevocable Trust 3 F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction involved a gift of securities by the Reporting Person. Disposition price is not applicable as this transaction was a bona fide gift.
F2 Includes 2,074 restricted stock units.
F3 The shares are held of record by The Tessier-Lavigne/Hynes Irrevocable Trust 1, for which the Reporting Person Serves as Trustee.
F4 The shares are held of record by The Tessier-Lavigne/Hynes Irrevocable Trust 2, for which the Reporting Person Serves as Trustee.
F5 The shares are held of record by The Tessier-Lavigne/Hynes Irrevocable Trust 3, for which the Reporting Person Serves as Trustee.